Massimo Porta

Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials

Nish Chaturvedi, Massimo Porta, Ronald Klein et al. · The Lancet · 2008 · 449 citations

Type 1, Diabetic Retinopathy, Ocular Disease +7

Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial

Anne Katrin Sjølie, Ronald Klein, Massimo Porta et al. · The Lancet · 2008 · 429 citations

Metabolic Syndrome, Hypertension, Diabetic Retinopathy +9

A 5-Year Randomized Controlled Study of Learning, Problem Solving Ability, and Quality of Life Modifications in People With Type 2 Diabetes Managed by Group Care

Marina Trento, P. Passera, E Borgo et al. · Diabetes Care · 2004 · 328 citations · Full text

Platelet-derived growth factor regulates the secretion of extracellular vesicles by adipose mesenchymal stem cells and enhances their angiogenic potential

Tatiana Lopatina, Stefania Bruno, Ciro Tetta et al. · Cell Communication and Signaling · 2014 · 311 citations · Full text

Group Visits Improve Metabolic Control in Type 2 Diabetes

Marina Trento, P. Passera, M. Tomalino et al. · Diabetes Care · 2001 · 298 citations · Full text